- Home
- ENVB vs SDSTW Comparison
ENVB vs SDSTW Comparison
Compare ENVB & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- SDSTW
- Stock Information
- Founded
- ENVB 1994
- SDSTW N/A
- Country
- ENVB United States
- SDSTW United States
- Employees
- ENVB N/A
- SDSTW 8
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- SDSTW
- Sector
- ENVB Health Care
- SDSTW
- Exchange
- ENVB Nasdaq
- SDSTW Nasdaq
- Market Cap
- ENVB 3.0M
- SDSTW 3.4M
- IPO Year
- ENVB N/A
- SDSTW N/A
- Fundamental
- Price
- ENVB $0.69
- SDSTW $0.10
- Analyst Decision
- ENVB Strong Buy
- SDSTW
- Analyst Count
- ENVB 1
- SDSTW 0
- Target Price
- ENVB $10.00
- SDSTW N/A
- AVG Volume (30 Days)
- ENVB 719.2K
- SDSTW 41.6K
- Earning Date
- ENVB 11-13-2025
- SDSTW 03-26-2025
- Dividend Yield
- ENVB N/A
- SDSTW N/A
- EPS Growth
- ENVB N/A
- SDSTW N/A
- EPS
- ENVB N/A
- SDSTW N/A
- Revenue
- ENVB N/A
- SDSTW N/A
- Revenue This Year
- ENVB N/A
- SDSTW N/A
- Revenue Next Year
- ENVB N/A
- SDSTW N/A
- P/E Ratio
- ENVB N/A
- SDSTW N/A
- Revenue Growth
- ENVB N/A
- SDSTW N/A
- 52 Week Low
- ENVB $0.56
- SDSTW $0.10
- 52 Week High
- ENVB $8.33
- SDSTW $0.12
- Technical
- Relative Strength Index (RSI)
- ENVB 40.87
- SDSTW 55.59
- Support Level
- ENVB $0.65
- SDSTW $0.08
- Resistance Level
- ENVB $0.78
- SDSTW $0.13
- Average True Range (ATR)
- ENVB 0.07
- SDSTW 0.02
- MACD
- ENVB 0.02
- SDSTW 0.00
- Stochastic Oscillator
- ENVB 45.71
- SDSTW 64.49
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).